Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 66 entries
View as:

Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT01410370 Org: User:
Start: 06/30/11 End: 06/30/13 Due: 06/30/14

Fluorouracil Implants Used for Intraperitoneal Chemotherapy During Operation for Treatment of Phase III Gastric Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT02269904 Org: User:
Start: 04/30/14 End: 06/30/18 Due: 06/30/19

PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04942301 Org: User:
Start: 07/30/21 End: 10/15/22 Due: 10/15/23

An Open Label, Multi-center, Phase I Clinical Study to Evaluate the Safety, Effectiveness and Pharmacokinetic Characteristics of SIM1803-1A in Patients With Locally Advanced/Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene Fusion Mutations.

Phase: N/A Priority: Normal
NCT ID: NCT04671849 Org: User:
Start: 12/21/20 End: 01/30/24 Due: 01/30/25

Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04902885 Org: User:
Start: 05/25/21 End: 12/31/22 Due: 12/31/23

Long-term Efficacy of Iguratimod Alone or Iguratimod in Combination With Methotrexate in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01548001 Org: User:
Start: 05/31/12 End: 01/31/17 Due: 01/31/18

Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02916420 Org: User:
Start: 09/30/16 End: 06/30/19 Due: 06/30/20

Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06326723 Org: User:
Start: 09/04/23 End: 02/05/24 Due: 02/05/25

Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01368419 Org: User:
Start: 05/31/11 End: 05/31/13 Due: 05/31/14

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06375044 Org: User:
Start: 05/24/24 End: 12/30/28 Due: 12/30/29

A Study of Iguratimod in Patients With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01554917 Org: User:
Start: 05/31/12 End: 08/31/15 Due: 08/31/16

Study to Investigate the Mass Balance and Biotransformation of SIM0417 in Healthy Adult Chinese Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT05475834 Org: User:
Start: 07/21/22 End: 08/07/22 Due: 08/07/23

Evaluate the Effects of Food on the Pharmacokinetics of SIM0270

Phase: N/A Priority: Normal
NCT ID: NCT06536036 Org: User:
Start: 07/23/24 End: 10/16/24 Due: 10/16/25

Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of Escalating Doses of SIM0348 as a Single Agent in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05718219 Org: User:
Start: 04/01/23 End: 12/30/25 Due: 12/30/26

A Pilot Bioequivalence Study of Pomalidomide

Phase: N/A Priority: Normal
NCT ID: NCT03424928 Org: User:
Start: 01/19/18 End: 02/06/18 Due: 02/06/19

Study of Endostar Subcutaneous Injection in NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02652234 Org: User:
Start: 08/31/15 End: 09/30/16 Due: 09/30/17

A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05148195 Org: User:
Start: 12/22/21 End: 07/26/23 Due: 07/26/24

Phase I Clinical Study of Metatinib Tromethamine Tablet

Phase: N/A Priority: Normal
NCT ID: NCT02004548 Org: User:
Start: 05/31/13 End: 12/31/15 Due: 12/31/16

A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04908787 Org: User:
Start: 06/11/21 End: 12/31/24 Due: 12/31/25

To Evaluate SSD8432/ Ritonavir in Adults With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05369676 Org: User:
Start: 05/12/22 End: 08/29/22 Due: 08/29/23

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

Phase: N/A Priority: Normal
NCT ID: NCT01327235 Org: User:
Start: 03/31/11 End: 07/31/14 Due: 07/31/15

A Phase I Clinical Study of SSD8432 in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05339646 Org: User:
Start: 04/07/22 End: 12/31/22 Due: 12/31/23

A Study of Daridorexant in Chinese Patients With Insomnia Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06010693 Org: User:
Start: 08/28/23 End: 05/10/24 Due: 05/10/25

A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT04830644 Org: User:
Start: 03/22/21 End: 06/30/22 Due: 06/30/23

The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01909856 Org: User:
Start: 10/31/11 End: 06/30/14 Due: 06/30/15